May 14, 2014

Press Release No. 1

News about Vivimed Labs Limited

The media had reports that “VIVIMED LABS Likely to Divest Stake in Speciality Chemicals Business.”

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

Vivimed Labs Limited has vide its letter inter-alia stated,"There are no such negotiations were taking place. The company is not aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading."

Press Release No. 2

News about SKS Microfinance Limited

The media had reports that "Akula Likely to Cut Ties with SKS Micro Soon."

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

SKS Microfinance Limited has vide its letter inter-alia stated,"None of the entities / person mentioned in the said article have approached SKS Microfinance Limited ("the Company") on any of the matters mentioned in the said article. Hence, we are unable to comment on the said article."

Press Release No. 3

Market-wide Position Limit in IBREALEST

The derivative contracts in the underlying IBREALEST have crossed 95% of the market-wide position limit on May 14, 2014. It is hereby informed that all clients/ members shall trade in derivative contracts of IBREALEST by offsetting their existing positions till the open interest comes down to 80% of the market wide position limit.

____________________________________________________________________________________